Immunohistochemically, the tumor cells were diffusely positive for pancytokeratin (AE1/AE3), focally positive for lipase and trypsin, and negative for cytokeratin 7, cytokeratin 20, CDX2, and endocrine markers such as chromogranin, synaptophysin, and CD56. This evidence concerns the gene KRT20 and neoplasm.